Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chemo enzymatic Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced preparation of tertiary alpha-aryl cyclic ketones via Pd-catalyzed coupling and enzymatic reduction. High purity pharmaceutical intermediates with scalable chemo-enzymatic technology.
Patent CN120944982A reveals high-yield ergothioneine production. Discover cost reduction in nutritional ingredients manufacturing and supply chain reliability.
Patent CN113881728B reveals a chemo-enzymatic route for PreQ 1, enhancing yield and reducing waste for pharmaceutical intermediate manufacturing supply chains.
Patent CN110343734B details a novel amidase method for L-glufosinate. Offers 100% theoretical yield and reduced environmental burden for agrochemical manufacturing.
Patent CN101085990A reveals chemo-enzymatic route for high-purity chiral alcohols. Enables cost reduction and supply chain reliability for pharmaceutical intermediates.
Analysis of patent CN101085990B reveals a chemo-enzymatic route for high-purity chiral alcohols. This method offers significant supply chain stability and cost reduction advantages for pharmaceutical intermediate manufacturing.
Patent CN109180496B details a novel lipase-catalyzed resolution and Mitsunobu reaction for Cinacalcet. Achieve high purity without hazardous reducing agents.
Patent CN102876759A details a chemo-enzymatic NAD preparation method offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel chemo-enzymatic route for diabetes drug intermediate offers high purity and scalable manufacturing solutions for global pharmaceutical supply chains efficiently.
Patent CN117025699A reveals a chemo-enzymatic route for Larotinib intermediates. Achieve high ee values and reduced costs with scalable pharmaceutical manufacturing solutions.
Patent CN114592027A reveals a novel two-step method for Tauroursodeoxycholic Acid production, offering significant cost reduction in API manufacturing and high-purity outcomes.
Patent CN102899367B details a hybrid bio-chemical synthesis for high-purity Tenofovir. This method offers significant cost reduction and scalable manufacturing for API intermediates.